Eurofins-Cerep SA (EPA:ALECR)
France · Delayed Price · Currency is EUR 17,400
+1,500 (9.43%)
At close: Feb 20, 2026
Eurofins-Cerep Market Cap
Eurofins-Cerep has a market cap or net worth of €87.77 million as of February 20, 2026. Its market cap has decreased by -15.53% in one year.
Market Cap
87.77M
Enterprise Value
74.18M
Revenue
38.86M
Ranking
n/a
PE Ratio
14.24
Stock Price
€17,400.00
Market Cap Chart
Since January 5, 2015, Eurofins-Cerep's market cap has decreased from 1.18B to 87.77M, a decrease of -92.55%. That is a compound annual growth rate of -20.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 87.77M | -2.25% |
| Dec 31, 2025 | 89.78M | -9.18% |
| Dec 31, 2024 | 98.86M | -21.60% |
| Dec 29, 2023 | 126.10M | 45.35% |
| Dec 23, 2021 | 86.76M | 32.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 110.27B |
| Sanofi | 96.10B |
| Sartorius Stedim Biotech | 17.78B |
| Ipsen | 12.95B |
| ABIONYX Pharma | 118.36M |
| Crossject Société Anonyme | 102.32M |
| AB Science | 97.60M |
| OSE Immunotherapeutics | 96.41M |